1-9 of 9
Frank Hartmann, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab and Bendamustine for First-Line Treatment of Frail or Elderly Patients with Aggressive B-Cell Lymphoma: Final Results of the Prospective Phase-II Brenda Trial of GLA (German Lymphoma Alliance)

Florian Zettl, Friederike Braulke, Marita Ziepert, PhD, Andreas Viardot, MD PhD, Christoph Kahl, MD, Gabriele Prange-Krex, Agnieszka Korfel, Martin H. Dreyling, MD PhD, Thomas Illmer, MD, Josef Birkmann, MD, Ulrich Wedding, Dietmar Reichert, Maike de Wit, MD, Frank Hartmann, MD, Hans-Juergen Hurtz, Norbert Schmitz, MD, Mathias Witzens-Harig, MD, Wolfram Klapper, Andreas Rosenwald, MD, Viola Poeschel, MD, Markus Loeffler, MD, Gerald Wulf, MD, Bettina Altmann, PhD, Lorenz Truemper, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4073.
https://doi.org/10.1182/blood-2019-122948
Published: 2019
Journal Articles

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Florian Kuchenbauer, MD PhD, Donald W. Bunjes, MD, Wolfgang Herr, MD, Michael Heuser, MD, Daniela Späth, MSc, Jochen Casper, MD, Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, MD, Guido Kobbe, MD, Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R Salih, MD, Katharina Götze, Gerald Wulf, MD, Matthias Theobald, MD PhD, Mathias J Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD PhD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, Uwe Martens, MD, Richard Greil, MD, Hartmut H. Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, PD, Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2014) 124 (21): 1254.
https://doi.org/10.1182/blood.V124.21.1254.1254
Published: 2014
Journal Articles

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Heuser, MD, Daniela Späth, MSc, Carina Morlok, Alexander Lamparter, Klaus-Henning Koehne, M.D., Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, Andrea Kündgen, M.D., Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R. Salih, MD, Katharina S. Goetze, MD, Gerald Wulf, MD, Matthias Theobald, MD, PhD, Mathias J. Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, MD, Uwe M. Martens, MD, Richard Greil, MD, Hartmut Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Sabine Kayser, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 3878.
https://doi.org/10.1182/blood.V122.21.3878.3878
Published: 2013
Journal Articles

Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3 -ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16-10 Trial

Sabine Kayser, MD, Mark Levis, MD, PhD, Carina Morlok, Andrea Kuendgen, MD, Michael Heuser, MD, Walter Fiedler, MD, Joerg Westermann, MD, Katharina Goetze, MD, Helmut R. Salih, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Heinz A. Horst, MD, Uwe M. Martens, MD, Gerald Wulf, MD, Michael Luebbert, MD, Ph.D., Dominik Wolf, MD, Richard Greil, MD, Claus-Henning Koehne, MD, Mark Ringhoffer, MD, Hartmut Kirchner, MD, Michael Pfreundschuh, MD, Brigitte Schlegelberger, MD, PhD, Patricia Erdmann, Trivikram Rajkhowa, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Arnold Ganser, Hartmut Doehner, MD, Konstanze Doehner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 1283.
https://doi.org/10.1182/blood.V122.21.1283.1283
Published: 2013
Journal Articles

The Genotype NPM1mut/FLT3-ITDneg Is a Highly Significant Predictive Factor for Response to Therapy with All-Trans Retinoic Acid in Acute Myeloid Leukemia - Results from AMLSG Trial AML HD98B.

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Kneba, MD, Francesco del Valle, MD, Frank Hartmann, MD, Heinz Kirchen, MD, Elisabeth Koller, MD, Katharina Götze, MD, Jörg Th. Fischer, MD, Marianne Habdank, Daniela Späth, Silja Groner, Andrea Corbacioglu, Axel Benner, MSC, Stefan Fröhling, Hartmut Döhner
Journal: Blood
Blood (2007) 110 (11): 297.
https://doi.org/10.1182/blood.V110.11.297.297
Published: 2007
Journal Articles

Combined Immuno-Chemotherapy Followed by Rituximab Maintenance Is an Effective Salvage Treatment after Prior Rituximab Containing Therapy: Results of a GLSG-Subgroup Analysis in Patients with Relapsed Indolent Lymphoma.

Martin H. Dreyling, MD, Roswitha Forstpointner, MD, Hans-Peter Boeck, MD, Roland Repp, MD, Hannes Wandt, MD, Christiane Pott, MD, John Francis Seymour, MD, Bernd Metzner, MD, Annette Haenel, MD, Tanja Lehmann, MD, Frank Hartmann, MD, Hermann Einsele, MD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD
Journal: Blood
Blood (2006) 108 (11): 2769.
https://doi.org/10.1182/blood.V108.11.2769.2769
Published: 2006
Journal Articles

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Rudolf Schmits, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Hans Steinhauer, MD, Marcel Reiser, MD, Michael Clemens, MD, Christine Nickenig, MD, Martha de Wit, MD, Martin Hoffmann, MD, Roland Mertelsmann, MD, Bernd Metzner, MD, Anthony Ho, MD, Lorenz Truemper, MD, Hans Eimermacher, MD, Hans Mergenthaler, MD, Ruediger Liersch, MD, Ulrich Duehrsen, MD, Leopold Balleisen, MD, Frank Hartmann, MD, Viola Poeschel, MD, Norbert Schmitz, MD, Markus Loeffler, MD
Journal: Blood
Blood (2005) 106 (11): 13.
https://doi.org/10.1182/blood.V106.11.13.13
Published: 2005
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Doehner, MD, Martina Kerz, Frank Hartmann, MD, Francesco del Valle, MD, Axel Glasmacher, MD, Hans Pralle, MD, Katharina Goetze, MD, Elisabeth Koller, MD, Guenther Gastl, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stephan Kremers, MD, Christoph Nerl, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Doehner, MD, for the German-Austrian, AML Study Group (AMLSG)
Journal: Blood
Blood (2005) 106 (11): 1849.
https://doi.org/10.1182/blood.V106.11.1849.1849
Published: 2005
Journal Articles

Improved Outcome in Adult T-ALL by Risk Adapted Treatment Strategies.

Nicola Goekbuget, MD, Eckhard Thiel, MD, Joachim Beck, MD, Frank Griesinger, MD, Frank Hartmann, MD, Kathleen Jentsch-Ullrich, MD, Sabine Knipp, MD, Thomas Lipp, MD, Dorle Messerer, Bernd Metzner, MD, Jan Rutjes, MD, Mathias Schmid, MD, Stefan Schwartz, MD, Peter Staib, MD, Matthias Stelljes, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2004) 104 (11): 682.
https://doi.org/10.1182/blood.V104.11.682.682
Published: 2004